Navigation Links
Venugopal will not be Sacked Before Court Verdict: Central Government

The central government Thursday assured the Delhi High Court that it would not sack All India Institute of Medical Sciences (AIIMS) director P. Venugopal from the post// till the court decided on his petition.

Additional Solicitor General Gopal Subramaniam gave this assurance to the court when counsel for Venugopal, Arun Jaitley, asked for a provision from the court on the government from acting upon the AIIMS governing body's recommendation of Wednesday.

Subramaniam submitted before Justice Anil Kumar that the government would not act upon the recommendation till the court decided on Venugopal's petition.

Venugopal, a renowned cardiologist, moved the high court following the governing body's resolution recommended the government to sack him for "violating the code of conduct".

Subramaniam also suggested to Jaitley to request Venugopal to relinquish the post on his own, following which the governing body would withdraw the recommendation for an amicable solution to the dispute.

Jaitley, however, showed little interest in the compromise formula saying that Venugopal's utmost concern was to protect the autonomy of the prestigious institute and there was no question of considering any out-of-court settlement unless the director's concern was addressed by the court.

Earlier Jaitley said the governing body's recommendation to remove Venugopal was malafide and unlawful as the body was not properly constituted.

He submitted that the health minister and the health secretary were nominated to the body in violation of the All India Institute of Medical Sciences Act.

However, Subramaniam argued that the governing body was in full legal competence to make the recommendation. He said a director of the institute could be removed like any other employee by serving him a three months' notice or three months' salary.

The matter will be heard further Friday.

(Source: IANS)
'"/>




Related medicine news :

1. Venugopal Should Not Have Gone Public: Ramadoss
2. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
3. AIIMS Director Venugopal Sacked
4. Delhi High Court Stays Venugopals Removal
5. Normalcy Returns To AIIMS; Venugopal Attends Office
6. AIIMS Official Files Complaint Against Venugopal
7. AIIMS Director Venugopal Removed from Additional Post
8. Court Issues Notice to Venugopal Over Fund Irregularities
9. Employees Sacked To Tackle Huge Debts Faced By the Hospital
10. AIIMS Director Venugopal Sacked
11. Australian State Health Official Sacked Following Poisoning Outbreak in Nursing Home
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... ... A product of digesting a micronutrient found in soy may hold the key ... while others do not, a University of Pittsburgh Graduate School of Public Health-led study ... some types of “good” gut bacteria when they metabolize isoflavones (micronutrients found in dietary ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Super-Sod will ... and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home ... Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed furniture from ...
(Date:2/22/2017)... ... ... BrightStar Care Charleston , a home care and medical staffing agency, ... Center on Aging’s Senior Expo on Thursday, March 23, 2017, at the Omar ... in our community. We are thrilled to participate in this event because we believe ...
(Date:2/22/2017)... ... February 22, 2017 , ... Apptricity® Corporation, a leading ... spend management, today announced that Keppel Corporation has selected Apptricity Travel and Expense ... , “We are excited to announce the partnership between Keppel and Apptricity for ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... five new hospital-grade power extension cords that meet the most current standards. , ... 2012 edition of the National Fire Protection Association (NFPA) 101 – Life Safety ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal ... therapies for both rare and common malignancies, today ... B financing. The company intends to use the ... and TK216, and to advance preclinical development of ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody ...
(Date:2/22/2017)... R.I. , Feb. 22, 2017  CVS Pharmacy ... the removal of partially hydrogenated oils (PHO), the primary ... all its exclusive store brands food products. The retailer ... which are free from artificial trans fats. This comes a ... Drug Administration,s deadline of June 2018 for processed foods ...
(Date:2/22/2017)... , Colombie-Britannique, February 22, 2017 Des scanners sur ... vente en Europe , au Moyen-Orient et en Afrique  ... Clarius Mobile Health , ... Vancouver , au Canada , a annoncé ... des Scanners Échographiques Sans fil Clarius C3 et L7, destinés à être ...
Breaking Medicine Technology: